We are live on ! Find out more
Jacobs Levy Equity Management

Jacobs Levy Equity Management Portfolio holdings

AUM $23.8B
1-Year Est. Return 25.4%
This Fund
S&P 500
This Quarter Est. Return
+6.28%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$5.18B
AUM Growth
-$419M
Cap. Flow
-$653M
Cap. Flow %
-12.61%
Top 10 Hldgs %
12.12%
Holding
1,157
New
156
Increased
241
Reduced
474
Closed
210

Sector Composition

Rank Sector Weight
1 Technology 18.78%
2 Financials 17.57%
3 Healthcare 14.1%
4 Industrials 10.7%
5 Consumer Discretionary 9.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TRU icon
776
TransUnion
TRU
$14.8B
$284K 0.01%
9,180
+2,070
+29% +$65.1K
DVA icon
777
DaVita
DVA
$15.1B
$283K 0.01%
4,410
-12,500
-74% -$778K
TRTN
778
DELISTED
Triton International Limited
TRTN
$281K 0.01%
+17,810
New +$285K
NL icon
779
NLI Holdings
NL
$284M
$280K 0.01%
34,405
NGVC icon
780
Vitamin Cottage Natural Grocers
NGVC
$691M
$276K 0.01%
+23,227
New +$276K
DHR icon
781
Danaher
DHR
$135B
$274K 0.01%
+3,971
New +$276K
MTW icon
782
Manitowoc
MTW
$516M
$273K 0.01%
11,425
MCHX icon
783
Marchex
MCHX
$79.7M
$270K 0.01%
101,863
-21,400
-17% -$56.6K
ELNK
784
DELISTED
EarthLink Holdings Corp.
ELNK
$269K 0.01%
+47,700
New +$272K
AMSF icon
785
AMERISAFE
AMSF
$569M
$268K 0.01%
4,300
-5,400
-56% -$328K
BMRC icon
786
Bank of Marin Bancorp
BMRC
$466M
$268K 0.01%
+7,680
New +$230K
LOGM
787
DELISTED
LogMein, Inc.
LOGM
$268K 0.01%
+2,780
New +$270K
STML
788
DELISTED
Stemline Therapeutics, Inc.
STML
$267K 0.01%
24,954
-26,289
-51% -$318K
NPTN
789
DELISTED
NEOPHOTONICS CORP
NPTN
$266K 0.01%
24,600
-17,051
-41% -$227K
DMTX
790
DELISTED
Dimension Therapeutics, Inc
DMTX
$266K 0.01%
61,207
+30,707
+101% +$163K
PRO
791
DELISTED
PROS Holdings
PRO
$260K 0.01%
+12,072
New +$276K
CC icon
792
Chemours
CC
$2.59B
$258K 0.01%
11,700
-106,300
-90% -$2.18M
OPY icon
793
Oppenheimer Holdings
OPY
$1.17B
$258K 0.01%
13,853
-2,100
-13% -$34.7K
FARO
794
DELISTED
Faro Technologies
FARO
$257K 0.01%
7,130
-1,760
-20% -$62.7K
PPLI
795
People Inc
PPLI
$3.1B
$257K 0.01%
22,214
-1,119
-5% -$13.1K
FMBI
796
DELISTED
First Midwest Bancorp Inc/IL
FMBI
$256K ﹤0.01%
+10,160
New +$224K
QNST icon
797
QuinStreet
QNST
$870M
$255K ﹤0.01%
67,705
-22,738
-25% -$73.8K
STC icon
798
Stewart Information Services
STC
$2.05B
$250K ﹤0.01%
5,420
-100
-2% -$4.49K
ARAV
799
DELISTED
Aravive, Inc. Common Stock
ARAV
$250K ﹤0.01%
2,800
-12,867
-82% -$975K
SEAC
800
DELISTED
Seachange International Inc
SEAC
$249K ﹤0.01%
5,405
-985
-15% -$51.4K

Similar funds

Jacobs Levy Equity Management's Q4 2016 Portfolio in Review

As of Q4 2016, Jacobs Levy Equity Management held 1,157 positions worth $5.18B, down 7.5% from $5.6B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Jacobs Levy Equity Management withdrew a net $653M in Q4 2016, closing 210 positions and reducing 474 holdings. Its most notable exit was Nike, an estimated $39.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Jacobs Levy Equity Management opened a new position in Express Scripts Holding Company worth $34.6M.

  • Jacobs Levy Equity Management's largest Q4 2016 buy was Express Scripts Holding Company: 502,999 shares worth $34.6M.
  • Jacobs Levy Equity Management added most to State Street SPDR S&P MIDCAP 400 ETF Trust in Q4 2016, an estimated $34.6M increase.
  • Jacobs Levy Equity Management's biggest Q4 2016 reduction was Alphabet (Google) Class C, cutting an estimated $34.2M.
  • Jacobs Levy Equity Management fully exited Nike in Q4 2016, selling an estimated $39.1M.
  • Jacobs Levy Equity Management's ten largest holdings make up 12% of its $5.18B portfolio in Q4 2016.
  • Jacobs Levy Equity Management opened 156 new positions and closed 210 in Q4 2016.
  • Jacobs Levy Equity Management's portfolio value fell 7.5% quarter-over-quarter to $5.18B.

Based on Jacobs Levy Equity Management's 13F filing for Q4 2016, filed 14 Feb 2017.